SCREEN Yourself for Cancer
Key facts
- Where
- Hershey, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 75 years old?
Source: NCT07927686, who can take part
Where in United States
- Pennsylvania State University College of MedicineHershey, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Milton S. Hershey Medical Center
- Trial code
- NCT07927686
- Record updated
- 10 November 2026
- Original description
This randomized controlled trial will evaluate whether evidence-based self-sampling tools improve the cancer screening process among underscreened patients. Participants who are eligible but out-of-date for colorectal cancer screening, cervical cancer screening, or both will be randomized to either usual practice or an intervention that includes mailed self-sampling tools for the appropriate cancer screening test. Primary outcomes include screening initiation (within 12 months of enrollment) and screening completion (within 18 months of enrollment), for each cancer type. Secondary outcomes include repeat screening adherence and receipt of diagnostic resolution following abnormal screening results.Read full original descriptionShow less
SCREEN Yourself for Cancer (Self-Collection Research Examining Engagement and Navigation)
This randomized controlled trial will evaluate whether evidence-based self-sampling tools improve the cancer screening process among underscreened patients. Participants who are eligible but out-of-date for colorectal cancer screening, cervical cancer screening, or both will be randomized to either usual practice or an intervention that includes mailed self-sampling tools for the appropriate cancer screening test. Primary outcomes include screening initiation (within 12 months of enrollment) and screening completion (within 18 months of enrollment), for each cancer type. Secondary outcomes include repeat screening adherence and receipt of diagnostic resolution following abnormal screening results.
Inclusion: active patient at Penn State Health Department of Family and Community Medicine; patients eligible but out-of-date for routine colorectal cancer screening and/or routine cervical cancer screening; able to read and write in English, Spanish, or Nepali.
Exclusion: patients ineligible for routine colorectal and/or cervical cancer screening; patients up-to-date on routine colorectal and/or cervical cancer screening (as applicable); not able to read and write in English, Spanish, or Nepali.